|
|
Blood, 1 March 2006, Vol. 107, No. 5, pp. 2112-2122.
Prepublished online as a Blood First Edition Paper on November 3, 2005; DOI 10.1182/blood-2005-01-0428.
Previous Article | Next Article 
Submitted January 31, 2005
Accepted October 17, 2005
A distinct and unique transcriptional programme expressed by tumor-associated macrophages: defective NF- B and enhanced IRF-3/STAT1 activation
Subhra K Biswas, Lisa Gangi, Saki Paul, Tiziana Schioppa, Alessandra Saccani, Marina Sironi, Barbara Bottazzi, Andrea Doni, Vincenzo Bronte, Fabio Pasqualini, Luca Vago, Manuela Nebuloni, Alberto Mantovani, and Antonio Sica*
Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
Laboratory of Molecular Technology, Microarray Research Group, National Cancer Institute-SAIC, Frederick, USA
Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy; Istituto clinico Humanitas, Milan, Milan, Italy
Department of Oncology and Surgical Sciences, Oncology Section, Padua University, Padua, Italy
Centro di Eccellenza per I'Innovazione Diagnostica e Terapeutica, State University of Milan, Institute of Pathology, Milan, Italy
Department of Clinical Sciences, State University of Milan, Institute of Pathology, Milan, Italy
Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy; Centro di Eccellenza per I'Innovazione Diagnostica e Terapeutica, State University of Milan, Institute of Pathology, Milan, Italy; Istituto clinico Humanitas, Milan, Milan, Italy
* Corresponding author; email: antonio.sica{at}humanitas.it.
To identify the molecular basis underlying the functions of Tumor-Associated Macrophages (TAM), we characterized the gene expression profile of TAM isolated from a murine fibrosarcoma in comparison with peritoneal macrophages (PEC) and immature suppressor cells (MSC), using a cDNA microarray technology. Among the differentially expressed genes, 15 genes relevant to inflammation and immunity were validated by real-time PCR and protein production. Resting TAM showed a characteristic gene expression pattern, with higher expression of genes coding for the immunosuppressive cytokine IL-10, phagocytosis-related receptors/molecules (Msr2 and C1q) and inflammatory chemokines (CCL2 and CCL5) as expected, as well as, unexpectedly, IFN-inducible chemokines (CXCL9, CXCL10, CXCL16). Immunohistology confirmed and extended the in vitro analysis by showing that TAM express M2-associated molecules (e.g. IL-10 and MGL1), as well as CCL2, CCL5, CXCL9, CXCL10 and CXCL16, but no appreciable NOS2. Lipopolysaccharide (LPS)-mediated activation of TAM resulted in defective expression of several proinflammatory cytokines (e.g. IL-1 , IL-6, TNF- ) and chemokines (eg. CCL3), as opposed to a strong up-regulation of immunosuppressive cytokines (IL-10, TGF ) and IFN-inducible chemokines (CCL5, CXCL9, CXCL10, CXCL16). The TAM functional profile was associated with defective activation of NF-kB but unexpected activation of MyD88-independent IRF-3 and STAT1.Thus, profiling of TAM from a murine sarcoma revealed unexpected expression of IFN-inducible chemokines, associated with an M2 phenotype (IL-10high, IL-12low), and divergent regulation of the NF- B versus the IRF-3/STAT1 pathway.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. M. Donson, D. K. Birks, V. N. Barton, Q. Wei, B. K. Kleinschmidt-DeMasters, M. H. Handler, A. E. Waziri, M. Wang, and N. K. Foreman
Immune Gene and Cell Enrichment Is Associated with a Good Prognosis in Ependymoma
J. Immunol.,
December 1, 2009;
183(11):
7428 - 7440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sica and A. Mantovani
Macrophage fusion cuisine
Blood,
November 19, 2009;
114(21):
4609 - 4610.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Solinas, G. Germano, A. Mantovani, and P. Allavena
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
J. Leukoc. Biol.,
November 1, 2009;
86(5):
1065 - 1073.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Ruffell, F. Mourkioti, A. Gambardella, P. Kirstetter, R. G. Lopez, N. Rosenthal, and C. Nerlov
A CREB-C/EBP{beta} cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair
PNAS,
October 13, 2009;
106(41):
17475 - 17480.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Mantovani and M. Locati
Orchestration of macrophage polarization
Blood,
October 8, 2009;
114(15):
3135 - 3136.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Porta, M. Rimoldi, G. Raes, L. Brys, P. Ghezzi, D. Di Liberto, F. Dieli, S. Ghisletti, G. Natoli, P. De Baetselier, et al.
Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor {kappa}B
PNAS,
September 1, 2009;
106(35):
14978 - 14983.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Fleetwood, H. Dinh, A. D. Cook, P. J Hertzog, and J. A. Hamilton
GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on Type I interferon signaling
J. Leukoc. Biol.,
August 1, 2009;
86(2):
411 - 421.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Pucci, M. A. Venneri, D. Biziato, A. Nonis, D. Moi, A. Sica, C. Di Serio, L. Naldini, and M. De Palma
A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships
Blood,
July 23, 2009;
114(4):
901 - 914.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Colotta, P. Allavena, A. Sica, C. Garlanda, and A. Mantovani
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Carcinogenesis,
July 1, 2009;
30(7):
1073 - 1081.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Bunt, V. K. Clements, E. M. Hanson, P. Sinha, and S. Ostrand-Rosenberg
Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4
J. Leukoc. Biol.,
June 1, 2009;
85(6):
996 - 1004.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Torroella-Kouri, R. Silvera, D. Rodriguez, R. Caso, A. Shatry, S. Opiela, D. Ilkovitch, R. A. Schwendener, V. Iragavarapu-Charyulu, Y. Cardentey, et al.
Identification of a Subpopulation of Macrophages in Mammary Tumor-Bearing Mice That Are Neither M1 nor M2 and Are Less Differentiated
Cancer Res.,
June 1, 2009;
69(11):
4800 - 4809.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Li, Y. Liu, S. Tuve, Y. Xun, X. Fan, L. Min, Q. Feng, N. Kiviat, H.-P. Kiem, M. L. Disis, et al.
Toward a stem cell gene therapy for breast cancer
Blood,
May 28, 2009;
113(22):
5423 - 5433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. del Fresno, F. Garcia-Rio, V. Gomez-Pina, A. Soares-Schanoski, I. Fernandez-Ruiz, T. Jurado, T. Kajiji, C. Shu, E. Marin, A. Gutierrez del Arroyo, et al.
Potent Phagocytic Activity with Impaired Antigen Presentation Identifying Lipopolysaccharide-Tolerant Human Monocytes: Demonstration in Isolated Monocytes from Cystic Fibrosis Patients
J. Immunol.,
May 15, 2009;
182(10):
6494 - 6507.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. White, T. Kambe, Y. G. Fulcher, S. W. Sachdev, A. I. Bush, K. Fritsche, J. Lee, T. P. Quinn, and M. J. Petris
Copper transport into the secretory pathway is regulated by oxygen in macrophages
J. Cell Sci.,
May 1, 2009;
122(9):
1315 - 1321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Hagemann, S. K. Biswas, T. Lawrence, A. Sica, and C. E. Lewis
Regulation of macrophage function in tumors: the multifaceted role of NF-{kappa}B
Blood,
April 2, 2009;
113(14):
3139 - 3146.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Leidi, E. Gotti, L. Bologna, E. Miranda, M. Rimoldi, A. Sica, M. Roncalli, G. A. Palumbo, M. Introna, and J. Golay
M2 Macrophages Phagocytose Rituximab-Opsonized Leukemic Targets More Efficiently than M1 Cells In Vitro
J. Immunol.,
April 1, 2009;
182(7):
4415 - 4422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. S. Ojalvo, W. King, D. Cox, and J. W. Pollard
High-Density Gene Expression Analysis of Tumor-Associated Macrophages from Mouse Mammary Tumors
Am. J. Pathol.,
March 1, 2009;
174(3):
1048 - 1064.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Weis, A. Weigert, A. von Knethen, and B. Brune
Heme Oxygenase-1 Contributes to an Alternative Macrophage Activation Profile Induced by Apoptotic Cell Supernatants
Mol. Biol. Cell,
March 1, 2009;
20(5):
1280 - 1288.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Edwards, X. Zhang, and D. M. Mosser
The Expression of Heparin-Binding Epidermal Growth Factor-Like Growth Factor by Regulatory Macrophages
J. Immunol.,
February 15, 2009;
182(4):
1929 - 1939.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Mantovani
Cancer-related Inflammation: The Seventh Hallmark of Cancer
ASCO Educational Book,
January 1, 2009;
2009(1):
723 - 726.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Holt, L. Cheng, and C. Ju
Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury
J. Leukoc. Biol.,
December 1, 2008;
84(6):
1410 - 1421.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Nonaka, M. Saio, T. Suwa, A. B. Frey, N. Umemura, H. Imai, G.-F. Ouyang, S. Osada, M. Balazs, R. Adany, et al.
Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes
J. Leukoc. Biol.,
September 1, 2008;
84(3):
679 - 688.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Guruvayoorappan
Tumor Versus Tumor-Associated Macrophages: How Hot is the Link?
Integr Cancer Ther,
June 1, 2008;
7(2):
90 - 95.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Tessem, J. N. Jensen, H. Pelli, X.-M. Dai, X.-H. Zong, E. R. Stanley, J. Jensen, and J. DeGregori
Critical Roles for Macrophages in Islet Angiogenesis and Maintenance During Pancreatic Degeneration
Diabetes,
June 1, 2008;
57(6):
1605 - 1617.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Umemura, M. Saio, T. Suwa, Y. Kitoh, J. Bai, K. Nonaka, G.-F. Ouyang, M. Okada, M. Balazs, R. Adany, et al.
Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics
J. Leukoc. Biol.,
May 1, 2008;
83(5):
1136 - 1144.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Bosschaerts, M. Guilliams, W. Noel, M. Herin, R. F. Burk, K. E. Hill, L. Brys, G. Raes, G. H. Ghassabeh, P. De Baetselier, et al.
Alternatively Activated Myeloid Cells Limit Pathogenicity Associated with African Trypanosomiasis through the IL-10 Inducible Gene Selenoprotein P
J. Immunol.,
May 1, 2008;
180(9):
6168 - 6175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Balestrieri, A. Balestrieri, F. P. Mancini, and C. Napoli
Understanding the immunoangiostatic CXC chemokine network
Cardiovasc Res,
May 1, 2008;
78(2):
250 - 256.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Worschech, M. Kmieciak, K. L. Knutson, H. D. Bear, A. A. Szalay, E. Wang, F. M. Marincola, and M. H. Manjili
Signatures Associated with Rejection or Recurrence in HER-2/neu-Positive Mammary Tumors
Cancer Res.,
April 1, 2008;
68(7):
2436 - 2446.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Biswas, A. Sica, and C. E. Lewis
Plasticity of Macrophage Function during Tumor Progression: Regulation by Distinct Molecular Mechanisms
J. Immunol.,
February 15, 2008;
180(4):
2011 - 2017.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Duluc, Y. Delneste, F. Tan, M.-P. Moles, L. Grimaud, J. Lenoir, L. Preisser, I. Anegon, L. Catala, N. Ifrah, et al.
Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells
Blood,
December 15, 2007;
110(13):
4319 - 4330.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Weigert, N. Tzieply, A. von Knethen, A. M. Johann, H. Schmidt, G. Geisslinger, and B. Brune
Tumor Cell Apoptosis Polarizes Macrophages Role of Sphingosine-1-Phosphate
Mol. Biol. Cell,
October 1, 2007;
18(10):
3810 - 3819.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Sinha, V. K. Clements, S. K. Bunt, S. M. Albelda, and S. Ostrand-Rosenberg
Cross-Talk between Myeloid-Derived Suppressor Cells and Macrophages Subverts Tumor Immunity toward a Type 2 Response
J. Immunol.,
July 15, 2007;
179(2):
977 - 983.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.-M. Kuang, Y. Wu, N. Chen, J. Cheng, S.-M. Zhuang, and L. Zheng
Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes
Blood,
July 15, 2007;
110(2):
587 - 595.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Ju, S. Katiyar, C. Wang, M. Liu, X. Jiao, S. Li, J. Zhou, J. Turner, M. P. Lisanti, R. G. Russell, et al.
Akt1 governs breast cancer progression in vivo
PNAS,
May 1, 2007;
104(18):
7438 - 7443.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Fleetwood, T. Lawrence, J. A. Hamilton, and A. D. Cook
Granulocyte-Macrophage Colony-Stimulating Factor (CSF) and Macrophage CSF-Dependent Macrophage Phenotypes Display Differences in Cytokine Profiles and Transcription Factor Activities: Implications for CSF Blockade in Inflammation
J. Immunol.,
April 15, 2007;
178(8):
5245 - 5252.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Saccani, T. Schioppa, C. Porta, S. K. Biswas, M. Nebuloni, L. Vago, B. Bottazzi, M. P. Colombo, A. Mantovani, and A. Sica
p50 Nuclear Factor-{kappa}B Overexpression in Tumor-Associated Macrophages Inhibits M1 Inflammatory Responses and Antitumor Resistance
Cancer Res.,
December 1, 2006;
66(23):
11432 - 11440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Edwards, X. Zhang, K. A. Frauwirth, and D. M. Mosser
Biochemical and functional characterization of three activated macrophage populations
J. Leukoc. Biol.,
December 1, 2006;
80(6):
1298 - 1307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Ness, J. L. Ewing, C. M. Hogaboam, and S. L. Kunkel
CCR4 Is a Key Modulator of Innate Immune Responses
J. Immunol.,
December 1, 2006;
177(11):
7531 - 7539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Dupasquier, P. Stoitzner, H. Wan, D. Cerqueira, A. van Oudenaren, J. S. A. Voerman, K. Denda-Nagai, T. Irimura, G. Raes, N. Romani, et al.
The dermal microenvironment induces the expression of the alternative activation marker CD301/mMGL in mononuclear phagocytes, independent of IL-4/IL-13 signaling
J. Leukoc. Biol.,
October 1, 2006;
80(4):
838 - 849.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Mantovani
Macrophage diversity and polarization: in vivo veritas
Blood,
July 15, 2006;
108(2):
408 - 409.
[Full Text]
[PDF]
|
 |
|
|
|